Distribution of a putative endogenous modulator of the GABA ergic system in human brain
Authors:
- 1 March 1989
- journal article
- research article
- Published by Wolters Kluwer Health in Neurology
- Vol. 39 (3) , 443
Abstract
Diazepam binding inhibitor (DBI) is a novel neuropeptide purified from rat, cow, and human brain that allosterically modulates GABA ergic transmission by binding to benzodiazepine (BDZ)-recognition sites. Using a specific radioimmunoassay for human DBI, we investigated the distribution of this peptide in different brain areas. We characterized with high-pressure liquid chromatography the DBI immunoreactivity in brain tissue obtained by biopsy and autopsy; we detected one molecular species of DBI in both instances. The regional distribution of DBI in the human brain is similar to that observed in rat brain: high concentrations in cortical and limbic areas, cerebellum, and brainstem, and low concentrations in the basal ganglia. These data suggest a modulatory role for DBI in human brain.Keywords
This publication has 1 reference indexed in Scilit:
- Huntington's diseaseNeurology, 1987